Incidence of microalbuminuria in hypertensive patients

Indian Journal of Clinical Biochemistry

Volumn 23, Issue 1, 2008, Pages 71-75

  Sabharwal, Ravjit Kaur ^a   Singh, Parduman ^a   Arora, M M ^a   Somani, B L ^a   Ambade, Vivek ^a  

^a ARMED FORCES MEDICAL COLLEGE   (India)

Author keywords

Albumin : Creatinine ratio; Hypertension; Microalbuminuria

Indexed keywords

ALBUMIN; CREATININE;

ADULT; AGED; ALCOHOLISM; ARTICLE; BODY MASS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MICTURITION; PREVALENCE; SMOKING; TURBIDIMETRY; URINALYSIS; URINARY EXCRETION;

EID: 45749122665     PISSN: 09701915     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12291-008-0017-3     Document Type: Article

References (29)

1. Parving HH, Jensen HE, Mogensen CE, Evrin PE. Increased urinary albumin excretion rate in benign essential hypertension. Lancet 1974; i: 1190-92.
2. Zuccala A, Fiorenza S, Rapana R, Santoro A. Hypertension, atherosclerosis and kidney. G Ital Nefrol 2005; 22 Suppl 31:S9-14.
3. Redon J, Pascual JM. Development of microalbuminuria in essential hypertension. Curr Hypertens Rep 2006; 8(2): 171-7
4. Parving HH. Microalbuminuria in essential hypertension and diabetes mellitus. J Hypertens 1996 Suppl; Sep: 14(2): S89-93: discussion S93-4.
5. Toto RD J. Microalbuminuria: definition, detection, and clinical significance. Clin Hypertens (Greenwich). 2004; 6 (11 Suppl 3): 2-7.
6. Lehmann R, Spinas GA, Schweiz Rundsch. Diabetic nephropathy: significance of microalbuminuria and proteinuria in Type I and Type II diabetes mellitus. Med Prax 1995; 84(44): 1265-71.
7. Sheth J, Trivedi B, Shah L, Sheth VS. Prevalence of microalbuminuria in diabetic subjects. J Assoc Physicians India 1993; 41(9):562-4.
8. Kshirsagar AV, Joy MS, Hogan SI, Falk RJ, Colinders RE. Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: a systematic overview of randomized placebo controlled trials. Am J of Kidney Dis 2000; 35(4): 695-707.
9. Shield JP, Hunt LP, Morgan JE, Pennock CA. Are frozen urine samples acceptable for estimating albumin excretion in research? Diabet Med 1995; 12(8): 713-6
10. Teppo A M Immunoturbidimetry of albumin and immunoglobulin G in urine. Clin Chem 1982; 28 : 1359-61
11. Rodby RA, Rohde RD, Sharon Z, Pohl MA, Bain RP, Lewis EJ. The urine protein to creatinine ratio as a predictor of 24-hour urine protein excretion in type 1 diabetic patients with nephropathy. The Collaborative Study Group. Am J Kidney Dis 1995; 26(6): 904-9.
12. Eshoj O, Feldt-Rasmussen B, Larsen ML, Mogensen EF. Comparison of overnight, morning and 24-hour urine collections in the assessment of diabetic microalbuminuria. Diabet Med 1987; 4(6): 531-3.
13. Goldschmid MG, Domin WS, Ziemer DC, Gallina DL, Phillips LS. Diabetes in urban African-Americans. II. High prevalence of microalbuminuria and nephropathy in African-Americans with diabetes. Diabetes Care 1995; 18(7): 955-61
14. Somani BL, Saha TK, Arora MM, Sharma YV. Modified bromophenol blue dye binding method for quantitation of microalbuminuria in diabetes mellitus. MJAFI 1995; 51: 110-16.
15. Caduff F, Spinas GA, Engler H, Achermann HR, Berger W. The practical assessment of microalbuminuria as a marker for beginning diabetic nephropathy in: which urine sampling method ? Schweiz Med Wochenschr 1991; 121(10): 324-31.
16. ADA Standards of medical care for patients with diabetes mellitus: Diabetic nephropathy. Diabet Care 2001; 24 Suppl I: S33-S43
17. Rosa TT, Palatini P. Clinical value of microalbuminuria in hypertension. J Hypertens 2000; 18(6): 645-54.
18. Cerasola G, Cottone S, Mule G. Microalbuminuria, renal dysfunction & cardiovascular complications in essential hypertension. J Hypertens 1996; 14:915-20.
19. Agrawal B, Berger A, Wolf K, Luft FC. Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension. J Hypertens 1996; 14:223-28.
20. Hallan H, Romundstad S, Kvenild K, Holmen J Microalbuminuria in diabetic and hypertensive patients and the general population - consequences of various diagnostic criteria - the Nord-Trondelag Health Study (HUNT). Scand J Urol Nephrol 2003; 37(2): 151-8.
21. Hornych A, Marre M, Mimran A, Chaignon M, Asmar R, Fauvel JP. Microalbuminuria in arterial hypertension. Measurement, variables, interpretation, recommendations. Arch Mal Coeur Vaiss 2000; 93(11): 1304-8.
22. Mimran A, Ribstein J, Du Cailar G. Microalbuminuria in essential hypertension. Current opinion in nephrology and hypertension 1999; 8(3): 359-63.
23. Col M, Ocaktan E, Ozdemir O, Yalcin A, Tuncbilek A Microalbuminuria: prevalence in hypertensives and diabetics.Acta Med Austriaca 2004 ; 31(1):23-9.
24. Pontremoli R, Sofia A, Ravera M. Prevalence and clinical correlates of microalbuminuria in essential hypertension: the MAGIC Study. Microalbuminuria: A Genoa Investigation on Complications. Hypertension 1997; 30(5): 1135-43.
25. Bigazzi R, Binachi S, Campese VM,Baldari G. Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. Nephron 1992; 61(1): 94-7.
26. Pedrinelli R, Dell'Omo G, Penno G, Di Bello V, Giorgi D, Pellegrini G, Del Prato S, Mariani M. Microalbuminuria, a parameter independent of metabolic influences in hypertensive men. Microalbuminuria is more frequent in obese hypertensives J Hypertens 2003 ; 21(6): 1163-9.
27. Redon J, Liao Y, Lozano JV, Miralles A, Baldo E, Cooper RS. Factors related to the presence of microalbuminuria in essential hypertension. Am J Hypertens 1994; 7 (9 Pt 1): 801-7.
28. Nishijo M, Nakagawa H, Morikawa Y. Microalbuminuria and hypertension in nondiabetic Japanese men. Am J Hypertens1999; 12(1Pt 1): 16-20.
29. Journath G, Nilsson PM, Petersson U, Paradis BA, Theobald H, Erhardt L. Hypertensive smokers have a worse cardiovascular risk profile than non-smokers in spite of treatment-a national study in Sweden. Blood Press 2005; 14(3): 144- 50.